Enrique Carrazana
2013
In 2013, Enrique Carrazana earned a total compensation of $1.6M as Chief Medical Officer at Acorda Therapeutics, a 36% increase compared to previous year.
Compensation breakdown
| Bonus | $2,500 |
|---|---|
| Non-Equity Incentive Plan | $161,868 |
| Option Awards | $729,094 |
| Salary | $416,033 |
| Stock Awards | $252,818 |
| Other | $56,532 |
| Total | $1,618,845 |
Carrazana received $729.1K in option awards, accounting for 45% of the total pay in 2013.
Carrazana also received $2.5K in bonus, $161.9K in non-equity incentive plan, $416K in salary, $252.8K in stock awards and $56.5K in other compensation.
Rankings
In 2013, Enrique Carrazana's compensation ranked 4,634th out of 12,286 executives tracked by ExecPay. In other words, Carrazana earned more than 62.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,634 out of 12,286 | 62nd |
Division Manufacturing | 1,588 out of 4,612 | 66th |
Major group Chemicals And Allied Products | 460 out of 1,462 | 69th |
Industry group Drugs | 321 out of 1,156 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 50 out of 196 | 75th |
Source: SEC filing on April 29, 2016.
Carrazana's colleagues
We found six more compensation records of executives who worked with Enrique Carrazana at Acorda Therapeutics in 2013.
2013
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2013
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2013
Jane Wasman
Acorda Therapeutics
General Counsel
2013
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2013
Lauren Sabella
Acorda Therapeutics
Chief Commercial Officer
2013
David Lawrence
Acorda Therapeutics